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Slower	immune	responses	
facilitate	early	transmission	events.
Conclusions	and	Perspectives
Is	Tasmanian	devil	doomed	to	extinction?	
Carcinogenesis is thought to occur via
accumulation of mutations and mutation
rates depend on cell number, which
correlates with body size and lifespan.
Then, large and long-lived animals
should have more cancers than smaller
and shorter-lived ones, due to increased
number of cell divisions.
Peto’s Paradox represents the lack of
correlation between cancer prevalence
and body size or lifespan and it can be
useful to explore cases that are far
from what is expected. Tasmanian
devils suffer from Devil Facial Tumor
Disease (DFTD), a lethal transmissible
cancer that is threatening the species
to extinction.
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tolerance
Deficiency	of	devil	
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downregulation
Marsupials’	immune	system	is	different	
from,	rather	than	inferior	to	mammals’	
immune	system.
MHC	is	regulated	by	histone	
modifications	affecting	the	acetylation	
state	of	β2m	and	TAP	promoters	
Similarities
Both	have	suffered	severe	
population	bottlenecks,	
which	caused low	genetic	
diversity	and	down-
regulation	of	MHC.
Differences
CTVT	has	had	grater	time	
to	evolve	than	DFTD,	and	
devils’	populations	have	
suffered	from	stronger	
decrease.
Dogs suffer from Canine Transmissible Venereal Tumor (CTVT). During the progressive
phase the immune system does not recognize tumor due to down-regulation of MHC.
However, after a period, tumor begins to regress as a result of significant increase in MHC
expression.
Parasite	evolution	
Attenuation	of	DFTD
Tasmanian	devil	evolutionary	
response
Development	of	a	vaccine
Evidence	of	resistance	
and	regression.
Immunization	with	adjuvants	
and	DFTD	cells	expressing	
MHC.
Methods
NCBI Pubmed search by using keywords combined with the appropriated Boolean
operators. To calculate devils’ cancer incidence I conducted a regression analysis
using Microsoft Excel.
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Introduction
Why	is	Tasmanian	devils’	cancer	incidence	so	high?
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Introduction	to	transmissible	cancers
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DFTD	outcome
Prediction	of	DFTD	evolution	based	on	comparative	biology
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Primary	
tumor’s	origin
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transmission
Lack	of	
allorecognition
Capacity	for	
infinite	growth
The ancestral type of DTDF is thought to be derived from a Schwann cell (clonal
origin) and it is transmitted by biting during mating or feeding interactions.
Reduction	of	DFTD	
pathogenicity.	
Although devils could evolve resistance to the disease, considering its much
larger effective population sizes, it is more likely that the tumor evolve towards
an attenuation of virulence.
Conservation	of	Tasmanian	devil
DFTD was first reported in
Mount William National Park,
northeastern Tasmania, in
1996. In 20 years, the disease
has spread to more than 85%
of wild Tasmanian devil
populations, causing severe
declines.
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y	= 0,0815 - 0,0061x
[y=%Tumors;	x=Log(Mass[x]*LifeSpan[y])]		
